Learning Objectives:
1. Discuss prevalence Non-alcoholic Fatty Liver Disease (NAFLD) and its natural history
2. Discuss the clinical presentation and evaluation process as directed by the NASPGHAN guidelines
3. Update on treatment modalities available for children with NAFLD
Session date:
02/20/2020 - 12:00pm to 1:00pm CST
Location:
ucmc
P-117
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Ruba K. Azzam, MD, MPH